WF
XBI icon

WealthTrust Fairport’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WealthTrust Fairport’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-107
Closed -$10K – 532
2018
Q3 		$10K Buy
+107
New +$10.4K ﹤0.01% 391

Other funds holding XBI

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

WealthTrust Fairport's XBI Position: Q4 2018 in Review

WealthTrust Fairport sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 107 shares — an estimated $10K sold.

WealthTrust Fairport first reported a position in XBI in Q3 2018 and held it in 1 quarter. The position peaked at $10K in Q3 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

  • WealthTrust Fairport reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
  • WealthTrust Fairport sold 107 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $10K.
  • WealthTrust Fairport first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 1 quarter.
  • WealthTrust Fairport's State Street SPDR S&P Biotech ETF position peaked at $10K in Q3 2018.
  • 427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on WealthTrust Fairport's 13F filing for Q4 2018, filed 25 Feb 2019.